Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04420754
Title Study of AIC100 in Relapsed/Refractory Thyroid Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AffyImmune Therapeutics, Inc.
Indications

thyroid gland anaplastic carcinoma

thyroid gland cancer

Therapies

AIC100

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.